137 related articles for article (PubMed ID: 20615925)
21. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
[TBL] [Abstract][Full Text] [Related]
22. Trans-4-lodo,4'-boranyl-chalcone induces antitumor activity against malignant glioma cell lines in vitro and in vivo.
Sasayama T; Tanaka K; Mizukawa K; Kawamura A; Kondoh T; Hosoda K; Kohmura E
J Neurooncol; 2007 Nov; 85(2):123-32. PubMed ID: 17530176
[TBL] [Abstract][Full Text] [Related]
23. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
[TBL] [Abstract][Full Text] [Related]
24. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
25. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
Fabris D; Rožman M; Sajko T; Vukelić Ž
Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
[TBL] [Abstract][Full Text] [Related]
26. Anti-Cancer Effect of Cap-Translation Inhibitor 4EGI-1 in Human Glioma U87 Cells: Involvement of Mitochondrial Dysfunction and ER Stress.
Wu M; Zhang C; Li XJ; Liu Q; Wanggou S
Cell Physiol Biochem; 2016; 40(5):1013-1028. PubMed ID: 27941351
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides.
Ma R; Koulov A; Moulton C; Basu M; Banerjee S; Goodson H; Basu S
Glycoconj J; 2004; 20(5):319-30. PubMed ID: 15229396
[TBL] [Abstract][Full Text] [Related]
28. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b.
Riboni L; Ghidoni R; Tettamanti G
J Neurochem; 1989 May; 52(5):1401-6. PubMed ID: 2709011
[TBL] [Abstract][Full Text] [Related]
29. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.
Lu J; Zhuang Z; Song DK; Mehta GU; Ikejiri B; Mushlin H; Park DM; Lonser RR
J Neurosurg; 2010 Aug; 113(2):225-33. PubMed ID: 20001590
[TBL] [Abstract][Full Text] [Related]
30. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788
[TBL] [Abstract][Full Text] [Related]
31. Ganglioside GD1b supresses immunoglobulin production by human peripheral blood mononuclear cells.
Kanda N; Tamaki K
Exp Hematol; 1999 Oct; 27(10):1487-93. PubMed ID: 10517489
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based ganglioside profiling provides potential insights into Alzheimer's disease development.
Li H; Liu Y; Wang Z; Xie Y; Yang L; Zhao Y; Tian R
J Chromatogr A; 2022 Aug; 1676():463196. PubMed ID: 35716462
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of ganglioside GD1b on K+ current in hippocampal neurons and its involvement in apoptosis suppression.
Chen X; Chi S; Liu M; Yang W; Wei T; Qi Z; Yang F
J Lipid Res; 2005 Dec; 46(12):2580-5. PubMed ID: 16199892
[TBL] [Abstract][Full Text] [Related]
34. Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.
Kim SM; Woo JS; Jeong CH; Ryu CH; Lim JY; Jeun SS
Cancer Res; 2012 Sep; 72(18):4807-17. PubMed ID: 22962275
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effects of LS-13 on glioma in vivo and in vitro.
Wang W; Xu X; Ji CY; Wu LY; Wang Z; Chen G
CNS Neurosci Ther; 2014 Oct; 20(10):947-9. PubMed ID: 25169817
[No Abstract] [Full Text] [Related]
36.
Cavdarli S; Delannoy P; Groux-Degroote S
Cells; 2020 Mar; 9(3):. PubMed ID: 32192217
[No Abstract] [Full Text] [Related]
37. The ganglioside GQ1b regulates BDNF expression via the NMDA receptor signaling pathway.
Shin MK; Jung WR; Kim HG; Roh SE; Kwak CH; Kim CH; Kim SJ; Kim KL
Neuropharmacology; 2014 Feb; 77():414-21. PubMed ID: 24184316
[TBL] [Abstract][Full Text] [Related]
38. Cultured cerebellar granule cells, but not astrocytes, produce an ester of ganglioside GD1b, presumably GD1b monolactone, from exogenous GD1b.
Bassi R; Riboni L; Tettamanti G
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):937-42. PubMed ID: 7945223
[TBL] [Abstract][Full Text] [Related]
39. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
40. Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.
Nitta Y; Shimizu S; Shishido-Hara Y; Suzuki K; Shiokawa Y; Nagane M
Cancer Med; 2016 Mar; 5(3):486-99. PubMed ID: 26778701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
